Very long chain fatty acids (policosanols) and phytosterols affect plasma lipid levels and cholesterol biosynthesis in hamsters

Metabolism: Clinical and Experimental

Volumn 54, Issue 4, 2005, Pages 508-514

  Wang, Yanwen ^a,c   Ebine, Naoyuki ^a   Jia, Xiaoming ^a   Jones, Peter J H ^a   Fairow, Clint ^b   Jaeger, Ralf ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Research and Development   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHYTOSTEROL; POLICOSANOL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL FOOD; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; HAMSTER; LIPID BLOOD LEVEL; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RODENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 15744398986     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.11.004     Document Type: Article

References (51)

1. R. Mas, G. Castano, and J. Illnait Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors Clin. Pharmacol. Ther. 65 1999 439 447
2. G. Castano, R. Mas, and J.C. Fernandez Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk J. Gerontol. A Biol. Sci. Med. Sci. 56 2001 M186 M192
3. M.L. Arruzazabala, D. Carbajal, and R. Mas Cholesterol-lowering effects of policosanol in rabbits Biol. Res. 27 1994 203 208
4. C. Rodriguez-Echenique, R. Mesa, and R. Mas Effect of policosanol chronically administered in male monkeys (Macaca arctoides) Food Chem. Toxicol. 32 1994 565 575
5. R. Menendez, M.L. Aruzazabala, and R. Mas Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet Br. J. Nutr. 77 1997 923 932
6. F. Hernandez, J. Illnait, and R. Mas Effect of ateromixol (policosanol) on serum lipids and lipoproteins in healthy volunteers Curr. Ther. Res. 51 1992 568 575
7. N. Crespo, J. Illnait, and R. Mas Comparative study of the efficiency and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus Int. J. Clin. Pharmacol. Res. 19 1999 117 127
8. K.A. Varady, P.J.H. Jones, and Y.W. Wang Policosanols: role in the prevention and treatment of cardiovascular disease Nutr. Rev. 61 2003 376 383
9. Y. Kabir, and S. Kimura Biodistribution and metabolism of orally administrated octacosanol in rats Ann. Nutr. Metab. 37 1993 33 38
10. 14C)- octacosanol in liver and muscle of rats after serial administration Ann. Nutr. Metab. 39 1995 279 284
11. H. Singh, and A.A. Poulos A comparative study of stearic acid and lignoceric acid oxidation by human skin fibroblasts Arch. Biochem. Biophys. 250 1986 171 179
12. H. Singh, N. Derwas, and A.A. Poulos Very long chain fatty acid beta-oxidation by rat liver mitocondria and peroxisomes Arch. Biochem. Biophys. 259 1987 382 390
13. R.J.A. Wanders, C.W.T. Van Roermund, and M.J.A. Van Wijland Studies of peroxisomal oxidation of palmitate and lignocerate in rat liver Biochim. Biophys. Acta 919 1987 21 25
14. L. Granlund, L.N. Larsen, and E.N. Christiansen Absorption of very long-chain saturated fatty acids in totally hydrogenated fish oil Br. J. Nutr. 84 2000 681 688
15. S. Mendoza, R. Gamez, and M. Noa Comparison of the effects of D-003 and policosanol on lipid profile and endothelial cells in normocholesterolemic rabbits Curr. Ther. Res. 62 2001 209 219
16. Y.W. Wang, P.J. Jones, and I. Pischel Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters Lipids 38 2003 165 170
17. R. Menendez, R. Mas, and A.M. Amor Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids Pharmacol. Res. 44 2001 299 304
18. R. Menendez, I. Fernandez, and A. del Rio Policosanol inhibits cholesterol biosynthesis and enhances LDL processing in cultured human fibroblasts Biol. Res. 27 1994 199 203
19. R. Menendez, A.M. Amor, and I. Rodeiro Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts Arch. Med. Res. 32 2001 8 12
20. P.M. Kris-Etherton, and J.M. Dietschy Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies Am. J. Clin. Nutr. 65 1997 1590S 1596S
21. P.J.H. Jones, D.E. MacDougall, and F.Y. Ntanios Dietary phytosterols as cholesterol-lowering agents in humans Can. J. Physiol. Pharmacol. 75 1997 217 227
22. P.J.H. Jones, F.Y. Ntanios, and M. Raeini-Sarjaz Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men Am. J. Clin. Nutr. 69 1999 1144 1150
23. P.J. Jones, M. Raeini-Sarjaz, and F. Ntanios Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters J. Lipid Res. 41 2000 697 705
24. T.A. Miettinen, M. Vuoristo, and M. Nissinen Serum, biliary, and fecal cholesterol and plant sterols in cholectomized patients before and during consumption of stanol ester margarine Am. J. Clin. Nutr. 71 2000 1095 1102
25. R.E. Ostlund, C.A. Spilburg, and W.F. Stenson Sitostanol administration in lecithin micelles potently reduces cholesterol absorption in humans Am. J. Clin. Nutr. 70 1999 826 831
26. F.Y. Ntanios, and P.J. Jones Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits Atherosclerosis 14 1999 341 351
27. L. Normen, P. Dutta, and A. Lia Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel Am. J. Clin. Nutr. 71 2000 908 913
28. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
29. K.R. Norum, T. Berg, and P. Helgerud Transport of cholesterol Physiol. Rev. 63 1983 1343 1419
30. P.J. Jones, and D.A. Schoeller Evidence for diurnal periodicity in human cholesterol synthesis J. Lipid Res. 31 1990 667 673
31. P.J. Jones, C.A. Leitch, and Z.C. Li Human cholesterol synthesis measurement using deuterated water. Theoretical and procedural considerations Arterioscler. Thromb. 13 1993 247 253
32. I.M. London, and H. Schwarz Erythrocyte metabolism; the metabolic behavior of the cholesterol of human erythrocytes J. Clin. Invest. 32 1953 1248 1252
33. P.J. Jones, C.A. Leitch, and R.A. Pederson Meal-frequency effects on plasma hormone concentrations and cholesterol synthesis in humans Am. J. Clin. Nutr. 57 1993 868 874
34. P.J.H. Jones, L.M. Ausman, and D.H. Croll Validation of deuterium incorporation against sterol balance for measurement of human cholesterol biosynthesis J. Lipid Res. 39 1998 1111 1117
35. M. Di Buono, P.J. Jones, and L. Beaumier Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis J. Lipid Res. 41 2000 1516 1523
36. P.J. Jones, A.S. Pappu, and D.R. Illingworth Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis Eur. J. Clin. Invest. 22 1992 609 613
37. N.R. Matthan, M. Raeini-Sarjaz, and A.H. Lichtenstein Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women Lipids 35 2000 1037 1044
38. F.Y. Ntanios, D.E. MacDougall, and P.J. Jones Gender effects of tall oil versus soybean phytosterols as cholesterol-lowering agents in hamsters Can. J. Physiol. Pharmacol. 76 1998 780 787
39. D. Lutjohann, C.O. Meese, and J.R. Croase III Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans J. Lipids Res. 34 1993 1039 1046
40. SAS Institute Inc SAS user's guide: Statistics, version 6.12 1994 SAS Institute, Inc. Cary (NC)
41. R.G.D. Steele, and J.H. Torrie Principles and procedures of statistics 2nd ed. 1980 McGraw-Hill New York (NY)
42. C.L. Aleman, M.N. Puig, and E.C. Elias Carcinogenicity of policosanol in mice: an 18-month study Food Chem. Toxicol. 33 1995 573 578
43. R. Gamez, C.L. Aleman, and R. Mas A 6-month study on the toxicity of high doses of policosanol orally administered to Sprague-Dawley rats J. Med. Food 4 2001 57 65
44. C. Aleman, I. Rodeiro, and M. Noa One-year dog toxicity study of D-002, a mixture of aliphatic alcohols J. Appl. Toxicol. 21 2001 179 184
45. I. Gouni-Berthold, and H.K. Berthold Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent Am. Heart J. 143 2002 356 365
46. R. Mas Policosanol Drugs Future 25 2000 269 586
47. F.Y. Ntanios, and P.J. Jones Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters Biochim. Biophys. Acta 1390 1998 237 244
48. G. Beaumier-Gallon, J. Lanfranchi, and M.F. Vergnes Method for simultaneous measurements of traces of heptadeuterated cholesterol and cholesterol by gas chromatography-mass spectrometry: application in humans J. Chromatogr. B Biomed. Sci. Appl. 718 1998 23 32
49. NCEP Summary of third report of NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults III JAMA 285 2001 2486 2497
50. R. Menendez, R. Mas, and A.M. Amor Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D003, a mixture of very long-chain saturated fatty acids Can. J. Physiol. Pharmacol. 80 2002 13 21
51. F.Y. Ntanios, P.J. Jones, and J.J. Frohlich Dietary sitostanol reduces plaque formation but not lecithin cholesterol acyl transferase activity in rabbits Atherosclerosis 138 1998 101 110